Featured
Read our handpicked blogs, curated for you.
|
CMOs do not struggle to justify campaigns; they struggle to prove Marketing ROI with hard numbers the board trusts. If…
|
Pharma marketers in India know the frustration well. Campaigns stall not because the idea is weak, but because the…
|
For Indian pharma, HCP engagement is no longer about reach; it’s about relevance and measurable impact. Boards want to…
Recent releases
|
Fixing MLR Bottlenecks: How Smart Tech Turns Compliance Into Growth
Ask any pharma CMO what slows marketing down, and the answer comes fast: MLR reviews. The Medical, Legal, and Regulatory process that’s supposed to keep pharma safe is also what keeps campaigns…
|
What CMOs Need from Their Next Agency (Hint: It’s Not Creative)
The myth of “big ideas”: Every CMO has heard it. Agencies pitch themselves as the home of big creative ideas. Bold campaigns. Stunning visuals. Award-winning decks. But here’s the uncomfortable truth…
|
The Future of Medical Education Campaigns: Platform-Driven, Not PowerPoint
For decades, medical education in pharma has meant one thing: slides. Decks for conferences. Decks for webinars. Decks for field reps to carry around on tablets. But here’s the truth: PowerPoint is…
|
Lifecycle Marketing in Pharma: The MarTech Blueprint
Pharma marketing has always been obsessed with “campaigns.” But campaigns start, peak, and fade. Doctors move on. Patients forget. Budgets get reset. What’s missing is continuity.Lifecycle marketing…
